Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Neoplasms

Explore clinical trials studying Central Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

1,870 public trials 483 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Neoplasms trial results

Active, Not Recruiting

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

NCT05438212

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +6 more
Locations
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 216 locations
View Trial Details
Active, Not Recruiting

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

NCT03604978

Conditions
Central Nervous System Neoplasms, Grade 2 Meningioma, Grade 3 Meningioma, +10 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer

NCT04739761

Conditions
Brain Diseases, Brain Neoplasms, Breast Cancer, +10 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Adelaide, Australia
  • Research Site Auchenflower, Australia
View all 81 locations
View Trial Details
Active, Not Recruiting

Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors

NCT06462222

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • The Affiliated Huizhou Hospital, Guangzhou Medical University Huizhou, Guangdong, China
  • Huizhou First Hospital Affiliated to Guangdong Medical University Huizhou, Guangdong, China
  • Beijing Chest Hospital, Capital Medical University Beijing, China
  • Cancer Center, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine Beijing, China
View Trial Details

Related conditions